关键数据
3.150今开
3.200最高
700.00成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.09%换手率
3.130昨收
3.050最低
2.19K成交额
亏损市盈率静
1.18市净率
0.00%股息率 TTM
-90.33%ROA
8.19052周最高
0.05量比
-46.63M净利润
720.00K总股本
-4.4418每股收益TTM
0.26Beta
-240.75%ROE
6.70052周最低
1.92%振幅
12.73%毛利率
2.30M总市值
0.95回报/风险
107.92%风险率

即将为您带来更多新闻,敬请期待。。。
Beyond Air Inc评分
-0.23与上次评分对比预测7.33
财务诊断4.97
技术分析6.06
公司估值9.47
机构认同度3.00
风险评估1.81
分析师评级
买入评级
20.000目标均价
+547.25%涨幅空间
Beyond Air Inc 最新财报电话会记录
Beyond Air (XAIR) 2027财年第一季度业绩电话会议:FDA催化剂,2026年800万美元展望
Beyond Air 2027财年第一季度营收维持在180万美元,毛利率升至13%,管理层重申了2026日历年800万美元的业绩指引。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
Beyond Air Inc 简介
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.
行业医疗设备与耗材
公司代码XAIR
员工数量61
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| Alyeska Investment Group, L.P. | 4.59% |
|---|
| Balyasny Asset Management LP | 3.66% |
|---|
| Carey (Robert F.) | 2.19% |
|---|
| Lisi (Steven A) | 1.37% |
|---|
| 股东类型 | 占比 |
|---|
| Hedge Fund | 8.31% |
|---|
| Individual Investor | 3.65% |
|---|
| Investment Advisor/Hedge Fund | 2.32% |
|---|
| Investment Advisor | 1.66% |
|---|
常见问题
Beyond Air Inc(XAIR)的当前股价是多少?
Beyond Air Inc(XAIR)的当前股价是 3.20。
Beyond Air Inc的股票代码是XAIR。
Beyond Air Inc股票的52周最高点是多少?
Beyond Air Inc股票的52周最高点是8.19。
Beyond Air Inc股票的52周最低点是多少?
Beyond Air Inc股票的52周最低点是3.10。
现在Beyond Air Inc(XAIR)的股票是买入、持有还是卖出?
根据分析师评级,Beyond Air Inc(XAIR)的总体评级为买入,目标价格为20.00。
Beyond Air Inc(XAIR)股票的每股收益(EPS TTM)是多少
Beyond Air Inc(XAIR)股票的每股收益(EPS TTM)是-4.44。